文献速递乳腺技术与安全USMR

对比增强超声联合常规超声与磁共振成像对恶性非肿块型乳腺病变诊断价值的比较

Comparison of the diagnostic value of contrast-enhanced ultrasound combined with conventional ultrasound versus magnetic resonance imaging in malignant non-mass breast lesions.
PubMed 文献 · Br J Radiol · 2023-07-03

该回顾性研究分析了109个经常规超声检出的非肿块型乳腺病变,比较对比增强超声联合常规超声与MRI的诊断效能。联合方法AUC为0.825,优于MRI的0.762(p=0.043);两种方法特异度均随病变增大而下降,但各大小亚组间AUC无显著差异。

要点

  • 对比增强超声联合常规超声诊断恶性非肿块型乳腺病变的AUC为0.825,优于MRI的0.762(p=0.043)。
  • 联合方法敏感度91.3%、特异度71.4%,MRI敏感度100%、特异度50.4%。
  • 两种方法特异度均随病变增大而下降,但敏感度不变。

核心结论

  • 对常规超声检出的非肿块型乳腺病变,对比增强超声联合常规超声的诊断效能可能优于MRI,但两种方法特异度均随病变增大而明显下降。

研究设计与样本

  • 回顾性分析109个经常规超声检出的非肿块型乳腺病变,均行对比增强超声和MRI检查,比较两种方法诊断恶性病变的效能。

关键影像表现/征象

  • 常规超声检出的109个非肿块型病变中,66个在MRI上表现为非肿块型强化。
  • 超声与MRI两种方法的一致率为60.6%。
  • 两种方法结果一致时,恶性概率更高。

诊断标准与关键数值

  • 总体样本中,对比增强超声联合常规超声诊断恶性非肿块型乳腺病变的敏感度91.3%、特异度71.4%、阳性预测值60%、阴性预测值93.4%、AUC 0.825。
  • 总体样本中,MRI诊断恶性非肿块型乳腺病变的敏感度100%、特异度50.4%、阳性预测值59.7%、阴性预测值100%、AUC 0.762。
  • 对比增强超声联合常规超声与MRI的AUC比较为0.825 vs 0.762,p=0.043。
  • 按病变大小(<10 mm、10-20 mm、>20 mm)亚组分析,两种方法AUC差异均无统计学意义(p>0.05)。

临床应用与阅片要点

  • 对常规超声检出的非肿块型乳腺病变,可参考对比增强超声联合常规超声与MRI的一致率60.6%,一致时恶性概率更高。
  • 需注意两种方法特异度均随病变增大而下降,大病变的诊断特异性可能降低。

局限性

  • 原文为回顾性分析。
  • 原文结论使用「may be better」表述,提示对比增强超声联合常规超声的诊断效能可能优于MRI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the diagnostic value of contrast-enhanced ultrasound (CEUS)+conventional ultrasound vs MRI for malignant non-mass breast lesions (NMLs).

METHODS: A total of 109 NMLs detected by conventional ultrasound and examined by both CEUS and MRI were retrospectively analysed. The characteristics of NMLs in CEUS and MRI were noted, and agreement between the two modalities was analysed. Sensitivity, specificity, positive-predictive value (PPV), negative-predictive value (NPV), and area under the curve (AUC) of the two methods for diagnosing malignant NMLs were calculated in the overall sample and subgroups of different sizes(<10 mm, 10-20 mm, >20 mm).

RESULTS: A total of 66 NMLs detected by conventional ultrasound showed non-mass enhancement in MRI. Agreement between ultrasound and MRI was 60.6%. Probability of malignancy was higher when there was agreement between the two modalities. In the overall group, the sensitivity, specificity, PPV, and NPV of the two methods were 91.3%, 71.4%, 60%, 93.4% and 100%, 50.4%, 59.7%, 100%, respectively. The diagnostic performance of CEUS+conventional ultrasound was better than that of MRI (AUC: 0.825 vs 0.762, p = 0.043). The specificity of both methods decreased as lesion size increased, but sensitivity did not change. There was no significant difference between the AUCs of the two methods in the size subgroups (p > 0.05).

CONCLUSION: The diagnostic performance of CEUS+conventional ultrasound may be better than that of MRI for NMLs detected by conventional ultrasound. However, the specificity of both methods decrease significantly as lesion size increases.

ADVANCES IN KNOWLEDGE: This is the first study to compare the diagnostic performance of CEUS+conventional ultrasound vs that of MRI for malignant NMLs detected by conventional ultrasound. While CEUS+conventional ultrasound appears to be superior to MRI, subgroup analysis suggests that diagnostic performance is poorer for larger NMLs.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang, Wang, Jin, et al. Comparison of the diagnostic value of contrast-enhanced ultrasound combined with conventional ultrasound versus magnetic resonance imaging in malignant non-mass breast lesions. Br J Radiol. 2023. PMID: 37393540. doi:10.1259/bjr.20220880

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。